These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7531800)

  • 21. Aprotinin in orthotopic liver transplantation.
    Bechstein WO; Riess H; Blumhardt G; Himmelreich G; Jochum M; Gerlach H; Rossaint R; Keck H; Neuhaus P
    Semin Thromb Hemost; 1993; 19(3):262-7. PubMed ID: 7689751
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of high-dose aprotinin to stabilize hemostasis in artificial circulation].
    Dement'eva II; Piatnitskaia GKh; Dzemeshkevich SL; Charnaia MA
    Anesteziol Reanimatol; 1993; (1):66-70. PubMed ID: 7524380
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of low doses of aprotinin in heart surgery].
    Blanco E; Blanco J; Bóveda S; Sierra J; Rubio J; Durán D; Alvarez J
    Rev Esp Anestesiol Reanim; 1994; 41(3):168-71. PubMed ID: 7520188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical use of aprotinin in cardiac surgery.
    Ciçek S; Tatar H; Demirkiliç U; Kuralay E
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):568-9. PubMed ID: 7543636
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to invited letter concerning: Aprotinin (J Thorac Cardiovasc Surg 1991; 101:1103-4).
    Blauhut B; Lundsgaard-Hansen P
    J Thorac Cardiovasc Surg; 1992 Feb; 103(2):386-7. PubMed ID: 1370972
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass.
    Carrel T; Bauer E; Laske A; von Segesser L; Turina M
    Lancet; 1991 Mar; 337(8742):673. PubMed ID: 1705649
    [No Abstract]   [Full Text] [Related]  

  • 29. Aprotinin versus tranexamic acid: the controversy continues.
    Levy JH
    Transfusion; 2006 Mar; 46(3):319-20. PubMed ID: 16533270
    [No Abstract]   [Full Text] [Related]  

  • 30. Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass.
    Angelini GD; Cooper GJ; Lamarra M; Bryan AJ
    Lancet; 1990 Mar; 335(8692):799-800. PubMed ID: 1690831
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of two different dosages of aprotonin on perioperative blood loss during liver transplantation.
    Ickx B; Pradier O; DeGroote F; Hendrice C; Toungouz M; Vandestadt J; Gelin M; Capel P
    Semin Thromb Hemost; 1993; 19(3):300-1. PubMed ID: 7689756
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraoperative coronary thrombosis: can aprotinin be incriminated?
    Royston D
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):137-41. PubMed ID: 7515702
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of minimal dose aprotinin on blood loss and fibrinolytic system-complement activation in coronary artery bypass grafting surgery.
    Cicekcioglu F; Cagli K; Emir M; Topbas M; Catav Z; Sener E; Tasdemir O
    J Card Surg; 2006; 21(4):336-41. PubMed ID: 16846409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modification of fibrinolysis of the injured rat brain by local application of aprotinin, hydrogen peroxide and physiologic NaCl solution].
    Leheta F; Lenz C; Weichenmeier I; Haas S; Blümel G
    Med Welt; 1982 Dec; 33(49):1802-4. PubMed ID: 6186889
    [No Abstract]   [Full Text] [Related]  

  • 35. Aprotinin: topical or systemic delivery in left ventricular assist device implantation.
    Hariawala MD
    Circulation; 1997 Oct; 96(8):2736-7. PubMed ID: 9355922
    [No Abstract]   [Full Text] [Related]  

  • 36. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dose the administration of low-dose aprotinin contribute to an anti-inflammatory effect in coronary artery bypass grafting?].
    Shirasawa B; Hamano K; Gohra H; Katoch T; Fujimura Y; Zempo N; Esato K
    Kyobu Geka; 1999 Oct; 52(11):943-5. PubMed ID: 10513162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct complications of sternal re-entry.
    Muthialu N
    Asian Cardiovasc Thorac Ann; 2006 Feb; 14(1):90. PubMed ID: 16432134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.